International Review of Ophthalmology

Previous Articles     Next Articles

New advance on endogenous endophthalmitis

FAN Yuan-yuan1, WEI Wen-bin2.   

  1. 1. Department of Ophthalmology, Zhejiang Province People's Hospital, Hangzhou 310014, China; 2. Beijing Tongren Eye Center,  Beijing Key Laboratory of Ophthalmology and Visual Science, Beijing Key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China
  • Received:2018-07-18 Online:2018-10-22 Published:2018-10-25
  • Contact: WEI Wen-bin, Email: weiwenbintr@163.com
  • Supported by:

    National Natural Science Foundation of China(81570891);Special Funds for Clinical Medicine Development of Beijing Hospital Authority(Sail Plan)(ZYLX201307);National Natural Science Foundation of China(81272981);National Natural Science Foundation of Beijing(7151003);Training Plan of High-level Health Technology Talents in Beijing Health System(2014-2-003)

Abstract:

Endogenous endophthalmitis (EE) is intraocular infection results from hematogenous seeding of the eye by bacteria or fungi. Visual outcome was poor in the majority of cases and mortality rate were frequently observed. Because multiple pathogenetic factors play a role, immunocompromised and immunocompetent patients both have the risk of EE.Lack of characteristic features in clinical manifestations that require rapid diagnosis and treatment to save vision. Cultures of the vitreous, aqueous, blood cultures and molecular diagnostic techniques, those have been used in research laboratories for rapid diagnosis are still being explored. Treatment essential for endogenous endophthalmitis are systemic therapy for the underlying infection and intravitreal antibiotics simultaneously, some cases also benefit from a surgical vitrectomy. Integration of medicine provides the reasonable management for EE patients. (Int Rev Ophthalmol, 2018, 42:  329-337)